Clinical Trial Update: INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for Telmisartan (Micardis) in incipient diabetic nephropathy, sponsored by Boehringer Ingelheim; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Nephropathies | Phase 4 | Status: COMPLETED